Evangelos Pefanis

Title: Evangelos Pefanis: Innovator in Chronic Liver Disease Research

Introduction

Evangelos Pefanis is a notable inventor based in Somers, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of chronic liver disease. With a total of 2 patents to his name, Pefanis is recognized for his innovative approaches to medical research.

Latest Patents

One of his latest patents is titled "HSD17B13 variants and uses thereof." This patent provides compositions related to HSD17B13 variants, including isolated nucleic acids and proteins associated with these variants. The patent also details methods for modifying cells using various agents, including nuclease agents and expression vectors. Furthermore, it outlines therapeutic and prophylactic methods aimed at treating individuals who are at risk of developing chronic liver disease.

Career Highlights

Evangelos Pefanis is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance his research in the field of biotechnology. His work focuses on the implications of HSD17B13 variants in chronic liver disease, contributing to the development of potential treatments.

Collaborations

Some of his notable coworkers include Noura S Abul-Husn and Omri Gottesman. Their collaborative efforts enhance the research environment and foster innovation within the company.

Conclusion

Evangelos Pefanis is a distinguished inventor whose work in chronic liver disease research is paving the way for new therapeutic approaches. His contributions to the field are invaluable and demonstrate the importance of innovation in medical science.